Treatment(s) already received-Surgical excision Posts on Medivizor
Navigation Menu

Treatment(s) already received-Surgical excision Posts on Medivizor

Can biological therapies nivolumab and ipilimumab prevent stage IV melanoma from returning?

Can biological therapies nivolumab and ipilimumab prevent stage IV melanoma from returning?

Posted by on Jun 6, 2020 in Melanoma | 0 comments

In a nutshell This study examined if biological therapies nivolumab (Opdivo) and ipilimumab (Yervoy) could safely prevent cancer return in patients with stage IV melanoma that has been surgically removed. The results showed that nivolumab and ipilimumab were effective at preventing recurrence but nivolumab alone was safer for patients. Some...

Read More

Restaging warranted prior to adjuvant therapy in patients with resected stage IIIB and IIIC melanoma.

Posted by on May 31, 2019 in Melanoma | 0 comments

In a nutshell This article investigated the need for restaging in patients with stage IIIB and IIIC melanoma before starting adjuvant therapy (AT; treatment after surgery).   The authors concluded that restaging should be considered for these high-risk patients before starting the AT.  Some background Melanoma a type of skin cancer...

Read More

PET is effective detecting recurrences in stage 3 melanoma

Posted by on Jun 4, 2018 in Melanoma | 0 comments

In a nutshell This study investigated the effectiveness of the imaging method PET (detects active cancer lesions) in detecting relapses after surgery in stage 3 melanoma patients. Researchers suggested that PET allows the detection of most recurrences. Some background Stage 3 melanoma is associated with a high rate of recurrences. Follow-up of...

Read More

Looking for participants to test the safety and effectiveness of a vaccine combined with TLR agonists to treat melanoma

Posted by on Feb 19, 2017 in Melanoma | 0 comments

In a nutshell This phase 1/2 trial aims to test the safety and effectiveness of a combined treatment with the new vaccine LPV7 and TLR agonists in advanced melanoma patients after surgery. The main outcome to be measured will be the treatment toxicity and response of the tumors to the treatment. This trial is recruiting in Houston, Texas and...

Read More

Factors that predict survival in thin melanoma

Posted by on Jul 5, 2015 in Melanoma | 0 comments

In a nutshell The authors analyzed the factors that affect the survival outcomes in the early stages of skin melanoma.  Some background The occurrence of early stage cutaneous (skin) melanoma is increasing. Tumor thickness (how deep the cancer reaches into the skin) at this stage is usually less than 1 mm. In early stage...

Read More